Rybelsus price in Spain: cost per dose (3, 7 and 14 mg) and per month

Rybelsus is oral semaglutide and in Spain it requires a medical prescription. If you are looking up what it costs per dose and per month, there is an important nuance: in 2026 the AEMPS announced that the old 3 mg, 7 mg and 14 mg presentations had been replaced by a new bioequivalent formulation of 1.5 mg, 4 mg and 9 mg. So when talking about prices, it is worth separating the historical price of the classic doses from the official price of the new presentations.

How much Rybelsus 3 mg, 7 mg and 14 mg costs in Spain

For the classic presentations, the summary of product characteristics sets a dosage of one tablet a day. That makes it possible to work out the cost per dose by dividing the pack price by 30 and, at the same time, to treat the monthly cost as the price of the 30-tablet pack.

For Rybelsus 14 mg, the official figure shown in the Ministry of Health's Nomenclátor is a retail price including VAT of €123.53 for 30 tablets. As a unit cost, that is €4.12 per dose and €123.53 a month. The Nomenclátor itself also lists it as withdrawn because it is no longer marketed, with effect from 1 May 2026.

For Rybelsus 3 mg and 7 mg, the Ministry of Health's Nomenclátor lists the same retail price including VAT as for 14 mg: €123.53 for 30 tablets, and both also appear as withdrawn because they are no longer marketed. On that basis, the cost per dose was €4.12 and the monthly cost €123.53 in all three cases.

What changed with Rybelsus in 2026

The relevant change is not just about price, but about the formulation and how the doses are named. In 2026 the AEMPS announced that the old 3 mg, 7 mg and 14 mg presentations were being replaced by a new bioequivalent formulation of 1.5 mg, 4 mg and 9 mg respectively. In other words, if you come across mixed information about 3, 7 and 14 mg today, it may be describing historical presentations rather than the ones currently marketed with the new formulation.

For those new 1.5 mg, 4 mg and 9 mg presentations, CIPM resolution 265 sets a maximum ex-factory price of €79.13 for 30 tablets for each of them, before margins and VAT. At the pharmacy, the Nomenclátor lists a retail price including VAT of €123.53 for all three: €4.12 per dose and €123.53 a month. That is the most useful official figure for understanding the current price after the 2026 change.

If you want to place this medicine in the wider context of GLP-1 receptor agonists, it may help to read what GLP-1 drugs are and how they work in obesity. And if you are after an overview of how semaglutide is used in Spain, you can also read Ozempic in Spain: what it is, how it works and who can take it.

Prescription, funding and what the visado means

Rybelsus remains a prescription-only medicine. In addition, the CIPM resolution establishes a special restriction within the Spanish National Health System, with dispensing subject to prior authorisation (visado) for the treatment of type 2 diabetes in people with a BMI ≥30 kg/m² on combination therapy, when diet and exercise are not enough to control blood glucose.

That regulatory framework matters because it rules out a simplistic reading of the price. It is not enough to know what a historical box cost or what a new presentation costs: it also matters which clinical situation its use is intended for within the National Health System. This ties in with metabolic problems that often go hand in hand, such as prediabetes or metabolic syndrome.

How to read the price per dose without getting confused

The most common confusion arises when old and new doses are mixed up as if they were simply interchangeable. The verified fact that can be stated is that there was a replacement with bioequivalent formulations, announced by the AEMPS. What you should not do is assume practical equivalences other than those in that official announcement, or infer changes in use from the price.

It is also worth separating the price paid at the pharmacy from the ex-factory price set by the CIPM. All six presentations, the old withdrawn ones and the new ones, appear in the official Nomenclátor with the same retail price including VAT of €123.53; the CIPM's €79.13 is the maximum ex-factory price, before margins and VAT. Confusing the two levels completely changes how each figure should be read.

The key points

The key idea is simple: in Spain Rybelsus requires a prescription, the classic 3, 7 and 14 mg doses changed in 2026 to 1.5, 4 and 9 mg, and not all the prices in circulation describe the same presentation or the same regulatory moment. Understanding that context avoids misleading comparisons. If what you are looking for is a serious assessment of your situation and of the options available in Spain today, at AiON you can access medical weight-loss treatment with a prior assessment, a prescription when appropriate from a registered doctor and ongoing follow-up. You can check in a few minutes whether this treatment suits your case.